Meeting
2022 ASCO Gastrointestinal Cancers Symposium
Survival of stage III colon cancer patients with adjuvant chemotherapy: Experience from a specialized cancer institute in Latinoamerica-Peru.
Authors
Eder Christian Veramendi Cabana
Instituto Nacional de Enfermedades Neoplásicas INEN (Peru), Lima, Peru
Eder Christian Veramendi Cabana , Jorge Antonio Cotito Izquierdo , Jackeline Macetas , Mariana Serrano , Cristian Pacheco , Victor Castro , Jhajaira M Araujo , Paola Catherine Montenegro
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Other
DOI
10.1200/JCO.2022.40.4_suppl.204
Abstract #
204
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2018 Gastrointestinal Cancers Symposium
Time to adjuvant chemotherapy in CEA-positive colon cancer: An NCDB analysis.
First Author: Yang Zhang
Poster
2014 ASCO Annual Meeting
Improved disease-free survival with intraportal chemotherapy plus adjuvant chemotherapy (mFOLFOX6) as adjuvant treatment in colon cancer.
First Author: Wenju Chang
Poster
2012 Gastrointestinal Cancers Symposium
Factors associated with delayed time to adjuvant chemotherapy (AC) in stage III colon cancer: British Columbia Cancer Agency (BCCA) cohort experience.
First Author: Angela Chan
Poster
2012 Gastrointestinal Cancers Symposium
Association between delays in adjuvant chemotherapy for stage III colon cancer and increased mortality.
First Author: Alex Bernard Haynes